The body content of calcium, phosphorus and magnesium is important, not only from the structural or supporting aspect, b~tt also from the aspect of cellular function. 1'1f embrane integri~y, nervous tissue conduction, neuromusc~tlar excitability, muscle contraction, hormone secretion, intermediary metabolism and synthesis, to mention but a few activities, are all l:nfluenced by these elements.
INTRODUCTION
Calcium, phosphorus and magnesium are major constituents of the body, and after excluding oxygen, carbon, hydrogen and nitrogen, these elements account for 50%, 25% and 1% respectively of the body's mass. Although structurally important, as calcium and phosphorus are the main inorganic components of bone, the physiological role of these elements is of even greater significance. It is from this point of view that the turnover of calcium, phosphorus and magnesium will be dIscussed, with httle attention being directed to metabolic bone disease, and uncommon conditions such as vitamin D resistance, osteopetrosis, hypophosphatasia and the pseudohypoparathyroid states.
The body content and turnover of calcium, phosphorus and magnesium and related disorders will be discussed as far as they are responsible for altered plasma concentrations of these elements. However, it must be remembered that significant derangements can occur without abnormally high or low plasma concentrations of calcium, phosphorus or magnesium, particularly in altered acid/base status, chronic renal and gastrointestinal tract disease, and drug induced abnormalities of vitamin D metabolism. Furthermore, abnormally high or low plasma concentrations of these ions can occur without significant disturbances of body content or turnover; such as may occur with hypoalbuminaemia (because almost half of plasma calcium is bound to albumin), haemo-concentration, or dilution, rapid intracellular fluxes that occur post-prandially (mediated by insulin stimulated cellular uptake of glucose) or haemolysed plasma samples provided for analysis (due to the intracellular release of magnesium and hydrolysis of phosphorus containing organic compounds).
Thus it is important to measure plasma concentrations of calcium, phosphorus and -naesthesia and Intensive Care, Vol. V, No. 4, November, 1977 magnesium under standard conditions: in the fasted state and using a non-tourniquet technique (Pain et al. 1975 ). On occasions it may be necessary to measure serum ultrafilterable calcium, ionized calcium, parathormone (Posen et al. 1976) , and vitamin D metabolites, as well as specific indicators of bone, renal or liver function to define abnormalities in the body content and turnover of calcium, phosphorus and magnesium.
The forms of calcium, phosphorus and magnesium normally present in plasma are shown in Table 1 . 
(1 2 Although yariously identified, in this re\'lew inorganic compounds containing phosphorus \\"i11 be collecti\'ely referred to as " plasma phosphorus". BODY COXTEXT, DISTRIBL'TIOX AXD TU1(XO\'ER Typical distributions of calcium, phosphorus and magnesium in a 70 kg adult man an: shown in Table 2 . The majority of these elements is found in bone. \\'hereas bone contains almost all calcium present in the body, this is not so for phosphorus or magnesium. Significant amounts of both these elements are present in soft tissues, where together with much smaller amounts of calcium they are important intracellular constituents. Despite the small amount of magnesium within the body when compared with calcium and phosphorus content, it is overall the fourth most abundant cation, and the second most abundant cation within cPIls.
DAILY
CALCIUM TURNOVER (Ca MW=40·08) FOOD BONE FIGL'I~E :.! .,-.\ \'eragc clail y phospllOrus turnover for a 71) kg adult man. Data derived form Nordin and Smith, 1966. 3 mmoljday for magnesiulll (N'ordin 1976). These suggestions are based on balance studies where attempts 11Jve been made to determine minimal oral intakes necessary to prevent negative balances. Calcium, phosphorus and magnesium from the diet and gastrointestinal Nordin, 1976. to be described in detail later. However, dietary intake and absorption can influence plasma concentrations of phosphorus ard magnesium. Low dietary intakes of phosphorus will result in hypophosphataemia, and high intakes ,vill be accompanied by increased urinary excretion of phosphorus (Nordin and Smith 1965) . The plasma concentrations of phosphorus and magnesium are affected by insulin stimulated uptake of glucose by celsl, which is accompanied not only by uptake of potassium, but also by uptake of phosphorus and magnesium. Thus ingestion of high carbohydrate containing diets or intravenous infusions 6th abundant 11th abundant element element of glucose, fructose, sorbitol or xylitol may be accompanied by hypophosphataemia and hypomagnesaemia. The normal values for plasma concentrations of calcium, phosphorus and magnesium are shown in Table 3 . Mineralization of bone is highly dependent upon adequate absorption of calcium and phosphorus from the gastrointestinal tract. Although factors influencing osteoblastic activity are not completely understood, alkaline phosphatase activity is involved and vitamin D3 or one of its metabolites may be required. However, it is certain that metabolites of Normal values for urinary excretion of calcium, phosphorus and magnesium are given in Table 3 . Whereas the dietary intake of phosphorus greatly influences its urinary excretion, the same cannot be said for calcium and magnesium. Like phosphorus, the urinary D. W. THO:\L\s excretions of calcium and magnesium depend upon the amount filtered by the glomerulus, which depends upon the plasma concentrations of free ions and small molecular weight species, and the amount re absorbed b\' the renal tubules. The former is much smallei' for calcium and magnesium, and the latter is inlluenced by a number of hormonal and other factors, som:~ of which will be (lescribed later. 
Calcillll1
~\lm()st all of the total body calcium (~jH()~) is present in h()ne, a,; part of tIll' ny,.;tal structure hydw.\:\'apatitc. ,\ltllough it can be \'il'wed as fulfilling a mechanical sUPIJ()rtillg functi()n, a small but signillcant proportion of this calciulll is readily e"clizll1geable \\,ith tllat in tIll' l'"tracdlular 'c()llIjlartl~1l'nt and ,;oft tissue,;. Bone tlllls provides an important pool of calcium which can Iw readily lllobilizel] to maintain norma] cOIlCl'ntrations in other areas of the bod \'.
'(jw integrit~, of cdl nH'mbranes, their perllwahility, adhesin'ness, and intL'rcdlular connections, and tIll' coupling of ('"citation (l1l'urally am] hormonally mediated) \\,ith electrical, contractile and secretory responses are functions dependent upon and mediated by local changes in ionizecl calcium concentration. E"ampiL's of cellular acti\'itil's which im'oh'e calcium include the svnaptic release of acetylcholine in rc,.;ponse to axonal depolarization, contraction of the heart following myocardial ccll membrane depolarization ane! the ,;ccretion of in,.;ulin induced by' hyperglycaemia. ~curo muscular activity is inversely related to e"tracellular ionized calcium ~ concentration, heing increaseel ",ith hypocalcaemia and resulting in tetany and cramps, and reduceel with hypercalcaemia wllich result,.; in muscular atOll\' ane! eventual paralysis. Calcium is also invol\'ed at one or more points in the complex pathway" leading to blood coagulation and activation of the complement system.
Since fluctuations in the concentration of calcium ha \'e significant effects Oil a number of the bod~"s tissues and organ systems, it 1S not surprising that the extracellular calcium concentration is maintained within narrow limits by an efficient feedback-controlled system (Fourman et al. lOoR, Popoutzer lUTH) . Such i,.; not the case for extracellular concentrations of phosphorus and magnesium, which are influenced more by intracellular uptake and renal excretion.
PllOSplzOYlts
Although phosphorus is also an important component of hone mineral, nearly LiO () of the total bocl\' content is found ill the soft tissues. Here phl;sphorus is present in a number of organic compounds. The lllost important of these is the nucleotide adeno,.;ine triphosphate (ATP), the labile high energy containing compound which is the final common provider of energ~' for all active p]()('esses: membrane transport, activation of intermediary mciabolites, ,;ynthetic patll\\,a\',;, muscular contraction, hormone secretion etc. Other phosphorus containing COll1POU1Hls incluele nucleic acids, pho,;ph()1 i pids and phospllOpmtl'ins which arc important cOl11p()]wnb of the structural and functional integrity of cells ane! their contents.
Due to the ability of in()rganic phosphate compounds to form acidic and ha~ic salts (H~PO~and
Hl'O.l.--)' they collstitute important componl'nts of intracellular and urinctry buffer sy~tellls. Phosphate salts form the majorit\· of titrable acid f()und in urine and hence are the main urinan' buffl'r.
The importance of phosJ)horus can be demonstrated hy thl' effeds of phosphate depletion. Although not usuall\' encountered where there is some form of fo()cl ingestion, hypopllOsphataemia is being ohsl'r\'ed more frequently with the increasing practice of parenteral feeding, and if uncorrected can kacl to phosphate depletion. This is associated with increasing weakness, occurrence of fits and eventual coma (EditoriaIIUTI).
agl/cs ill III
Almost half of the body's magnesiuIll i" found intracellularly in the soft tissues. Here it is second to potassium as a major intracellular cation, hut in contrast to potassium, it is specificalh' associated with the function of a number of intracellular structures and organelles.
Important sites of action arc enzymes whose functions depend upon the presence of magneSlUm. ;\mongst magnesium reqUInng enzymes are ATPases, enzymes catalysing transfer of high energy phosphate bonds, acid and alkaline phosphatases, enzymes required for synthesis of protein and nucleic acids, peptidases, ribonucleases, enzymes of glycolysis and car bo"ylase reactions. :'lagnesium is often associated with enzyme systems that require thiamine pyrophosphate a" cofactor and many lose their activity if magnesium is removed.
:'Iagnesium is also important in the processes of nerve conduction, neuromuscular activity and Anaesthesia and Intensive Care, !'ol. [', Xo. -I, Xovembcr, 1977 CALCIUM, PHOSPHORUS AND MAGNESIUM TURNOVER 3G5 muscle function, having properties similar to those of calcium. Thus decreased extracellular concentrations of magnesium are associated with paraesthesiae, increased neuromuscular excitability, tetany and cramps, whereas hypermagnesaemia is associated with depressed nervous system activity, muscular atony and cardio-respiratory collapse. However, such effects are less frequently associated with disturbances in the body content and turnover of magnesium than of calcium. This no doubt is due to the large pools of exchangeable magnesium found in soft tissues and bone, although factors regulating extracellular magnesium concentrations are poorly understood (Alfrey 1976 ).
FACTORS REGULATING CALCIUM, PHOSPHORUS
AND .MAGNESIUM TURNOVER Vitamin D Cholecalciferol (Vitamin D 3 ) derived from ultraviolet irradiation of 7 dehydrocholesterol in the skin, or ergocalciferol (Vitamin D 2 ) consumed in the diet, are hydroxylated in the liver to 25 OH-cholecalciferol (25 OH-D3)' This microsomal process is regulated by the intrahepatic concentration of 25 OH-D3' and influenced by many inducers of hepatic microsomal activity to produce more polar, but less active, derivatives. These are excreted in the bile to leave less 25 OH-D3 for further hydroxylation by the kidney.
The 25 OH-D3 normally produced by the liver is transported on a specific y-globulin binding-protein to the kidney where further hydroxylaton occurs at the 1-or 24-positions. The hydroxylating enzyme responsible for the formation of 1,25 DiOH-D3 is stimulated by parathormone and low intracellular concentrations of inorganic phosphorus and inhibited by high concentrations of calcium. The formation of 24, 25 DiOH-D3 is stimulated by high intracellular concentrations of inorganic phosphorus and calcium and inhibited by parathormone.
The vitamin D derivative 1,25 DiOH-D3 has extreme biological potency stimulating calcium and phosphorus absorption from the gastrointestinal tract, resorption from bone and reabsorption by the renal tubules, and is thought to be the major active vitamin D derivative. The other derivatives formed by the kidney, predominantly 24, 25 DiOH-D3' are thought to be biologically inactive. Thus, vitamin D promotes a net flux of calcium and phosphorus into the extracellular compartment so necessary for maintenance of intracellular concentrations in the soft tissues and adequate mineralization of bone. The formation of 1,25 DiOH-D3 is stimulated by low concentrations of these ions which thus constitute the afferent arc of a feedback loop (DeLuca 1976, and Popoutzer 1976) .
Parathormone
Low circulating concentrations of calcium, magnesium, and other divalent cations also stimulate the chief cells of the parathyroid glands to release parathormone, a single chain 84 amino acid containing polypeptide with molecular weight of 9,500, into the circulation. The biological activity of this hormone, a property of the N-terminal half of the molecule, is confined to bone and kidney tissues. Bone resorption is stimulated by increased osteocytic and osteoclastic activity, which results in the release of calcium and phosphorus into the extracellular compartment. This process is said to require the participation of 1,25 DiOH-D3' and certainly can be augmented by excessive amounts of this derivative. In the kidney parathormone exerts its effect on the renal tubules by stimulating reabsorption of calcium and magnesium and inhibiting reabsorption of phosphorus.
This constitutes another homeostatic mechanism, under feedback control, predominantly for the precise regulation of the extracellular calcium concentration. Hypocalcaemia stimulates parathormone which mobilizes calcium and phosphorus from bone, increases gastrointestinal absorption of calcium and phosphorus (by inducing formation of 1,25 DiOH-D3) and permits the kidney to retain the calcium and excrete the phosphorus. As the concentrations of calcium and phosphorus rise, the stimulus for parathormone release abates, and the inactive 24, 25 DiOH-D3 is formed instead of the active 1,25 DiOH-Da derivative.
Calcitonin
A polypeptide containing 32 amino acids is released from the parafollicular or C-cells of the thyroid when stimulated by high extracellular concentrations of calcium. This substance has a number of effects which can lower the extracellular concentration of calcium. Bone resorption is inhibited, renal excretion of calcium and phosphorus is increased whereas the excretion of magnesium is reduced, and possibly gastrointestinal absorption of calcium and phosphorus is reduced too. There is little evidence, however, that calcitonin has a physiological function in the homeostatic control of the body content and turnover of calcium, phosphorus or magnesium. It is phylogenetically much older than parathormone, and is considered by some to be merely a vestigial hormone (Popoutzer 1976 ).
Nevertheless, calcitonin has several valuable therapeutic uses. Its hypocalcaemic action can be used to manage patients with resistant hypercalcaemia which has failed to respond to rehydration, sodium diuresis or phosphate administration. This is most commonly observed in patients with hypercalcaemia resulting from tumour deposits in bone. Striking results have been obtained in patients with Paget's Disease, in whom use is made of calcitonin's ability to suppress bone resorption. Invariably there is evidence of a profound reduction in bone turnover following prolonged intramuscular administration of calcitonin, and this is often associated with pain relief.
Po;-- The interactions of vitamin D, parathormone and possibly calcitonin in the homeostatic regulation of extracellular calcium concentration are illustrated in Figure 4 .
Despite the complexity of this system the end result is the effective maintenance of extracellular calcium concentrations within quite narrow limits. This is achieved with amazing accuracy and precision. Such control is necessary for processes such as nervous system conduction, neuromuscular excitation and muscle contraction are profoundly influenced by quite small fluctuations in ionized calcium concentration (Popoutzer 1976) .
The need for similar control of phosphorus concentrations within narrow limits is not apparent. Indeed significant fluctuations in plasma phosphorus concentrations occur throughout each day. Furthermore, no direct mechanism controlling extracellular phosphorus concentrations has been identified although an indirect mechanism has been proposed. Low concentrations of intracellular inorganic phosphorus stimulate the formation of 1 ,25 DiOH-D3' This promotes increased gastrointestinal absorption of calcium and phosphorus. In the presence of normal extracellular concentrations of calcium, the ensuing rise in calcium concentration will suppress parathormone release. In the absence of parathormone, the kidney excretes calcium, but under the influence of 1,25 DiOH-D3 phosphate reabsorption occurs, thus restoring body phosphorus content to normal. However, some claim that 1,25 DiOH-D3 increases reabsorption of calcium as well as phosphorus.
Nevertheless, the kidney can profoundly influence the body content of phosphorus. As a result of disordered tubular function, whether congenital or acquired, phosphate reabsorption can be impaired with increased phosphate excretion, hypophosphataemia and phosphorus depletion. \\'ith reduced rates of glomerular filtration phosphate excretion is impaired, and hyperphosphataemia appears together with the other manifestations of renal failure.
There is evidence that the body content of magnesium is under some form of control. Magnesium is effectively taken up by cells to maintain intracellular concentrations, but regulatory influences are unknown. Gastrointestinal absorption of magnesium occurs by an unknown process, and is influenced by a number of factors. Yitamin D or its metabolites, parathormone and growth hormone appear to facilitate magnesium absorption, whereas high dietary intakes of calcium, phosphorus, fat and phytates appear to reduce magnesium absorption, either by competing for absorption or forming insoluble complexes with magnesium in the lumen of the gastrointestinal tract. The kidney exerts a major influence on magnesium turnover. Renal tubular reabsorption is increased by parathormone and when calcium intakes are low.
Reduced renal tubular reabsorption occurs
Anaesthesia and Intensive Care, Vol. V, 1'-0. 4, November, 1977 when calcium and magnesium intakes are high, in the presence of aldosterone, thyroid hormone, growth hormone and antidiuretic hormone, and with the use of diuretics and excessive consumption of alcohol (Alfrey 1976) .
Other factors
Some specific effects of other hormones should be mentioned, not for their effects on the normal content and turnover of calcium, phosphorous and magnesium, but for changes that can occur in association with a variety of endocrinopathies and other abnornlal states.
Thyroxine and tri-iodothyronine increase bone calcium and phosphorus turnover and reduce renal tubular reabsorption of magnesium. In thyrotoxicosis hypercalcaemia can occur as a tesult of increased bone mineral turnover, and hypermagnesaemia can be seen in association with hypothyroidism.
Growth hormone induces retention of calcium and magnesium in bone, increases intestinal absorption of calcium and phosphorus and reduces renal tubular reabsorption of phosphorus and magnesium. These effects no doubt explain the small but obviously significant positive balances of calcium, phosphorus and magnesium that occur during the years of growth. This is characterized by hyperphosphataemia which can also accompany active acromegaly.
Glucagon can produce a fall in plasma calcium concentration, either by directly suppressing bone resorption or producing a release of calcitonin. This effect has been postulated as a cause of hypocalcaemia that occurs during acute pancreatitis.
Glucocorticoids inhibit calcium absorption from the gastrointestinal tract, inhibit bone resorption and promote calcium and phosphorus excretion in urine. Although disturbances in plasma calcium and phosphorus concentrations are not characteristic features of glucocorticoid excess, loss of bone mineral (possibly the result of secondary hyperparathyroidism) and matrix (as a result of reduced protein synthesis) are distressing complications of glucocorticoid excess.
DISORDERS OF TURNOVER OF CALCIUM, PHOSPHORUS AND MAGNESIUM
Most of the major causes of altered plasma concentrations of calcium, phosphorus and magnesium are given in the following tables, together with outlines of their clinical manifestations and treatment. Such conditions must be kept in mind when patients with paraesthesia, tetany, muscle cramps or paralysis, cardiac arrhythmias, drowsiness, mental changes, seizures or altered states of consciousness are being assessed, particularly in clinical settings of malignancy, bone disease, renal impairment, endocrine abnormalities, intravenous nutrition, and previous neck surgery or trauma. Occasionally these conditions can present a life-threatening situation that requires the prompt recognition and intervention which can only be achieved by constant clinical awareness.
Abnormalities of Calcium Homeostasis
The commonest causes of hypercalcaemia are malignancy, in the various forms that can affect bone, and primary hyperparathyroidism (Aurbach et al. 1973) . Although the separation of these can be difficult (Posen et al. 1976 ) the treatment of extreme hypercalcaemia should never be postponed until the cause is established. Hypercalcaemia is usually associated with a renal concentrating defect and vomiting, so that fluid and electrolyte depletion are usually present and may often exacerbate the hypercalcaemia. The first line of management should always be correction of dehydration, thereafter a forced sodium diuresis (Newmark and Himathongkam 1974) or administration of a neutral phosphate solution can be used (Goldsmith and Ingbar 1966) . The latter, however, is contraindicated by the presence or occurrence of reduced glomerular filtration. Hypercalcaemia associated with malignancy can be difficult to correct, and may often require the use of several hypocalcaemic measures, singly or in combination (Newmark and Himathongkam 1974) .
The occurrence of paraesthesiae, tetany and muscle cramps should quickly permit confirmation of hypocalcaemia, although its cause may be obscure. Vitamin D deficiency, once a clinical diagnosis confirmed by therapeutic trial, can now be diagnosed by specific assay of 25 OH-D3. ~agnesium depletion is an important cause of hypocalcaemia and should be kept in mind, particularly when other causes have not been found (Medalle and Waterhouse 1973) . The usual treatment for hypocalcaemia consists of oral supplements of calcium and vitamin D. Individual responses can be quite variable and treatment must be constantly monitored. Persisting hypocalcaemia and hypercalcaemia are frequent enough complications to justify this vigilance. Acute hypocalcaemia can be managed with intravenous infusions of calcium gluconate (Newmark and Himathongkam 1974) . CfilliClfI .\l({IIi(, 's'atioll, < IIlId 1'1'(lItllll"lll oj HY/'tralld Hv/, venting its absorption, Hypophosphataemia complicating intravenous glucose administration or parenteral feeding regimes can be more of an acute problem, due to the various metabolic defects associated with phosphate depletion, Prorr?pt correction of this situation often reqUlres the use of intravenous phosphate solutions, which should also be considered for preventative use in patients recelvmg long term parenteral nutrition (Editorial 1977) , Abnormalities of Magnesium Homeostasis Hypermagnesaemia is rarely encountered, but when it occurs, it is usually in association with chronic renal failure, particularly if magnesium containing antacids have been used inadvertently. Quite severe degrees of hypermagnesaemia can occur before significant effects are noted. However, the occurrence of cardiac conduction defects is an indication for prompt management with calcium supplements and a forced sodium/calcium diuresis. This latter technique, as with a forced sodium diuresis used in the management of hypercalcaemia, must be executed with great care. Careful attention to urine output and electrolyte content should prevent overloading or depleting effects, which are prone to occur in patients with compromised cardiac and/or renal function. Low plasma magnesium concentrations like hypocalcaemia produce paraesthesiae, tetany and muscle cramps. However, failure to respond to calcium replacement should immediately alert one to the possibility of hypomagnesaemia. Oral replacement can be quite effective, and doses of 60 to 70 mmol/day can be used without inducing diarrhoea. Intravenous replacement should be used when rapid correction of magnesium depletion is required. There is little need to employ intramuscular injections of magnesium salts. These are painful and rarely can sufficient volumes be injected to effectively manage magnesium depletion (Alfrey 1976 ).
